United Therapeutics CEO Martine Rothblatt Sells $1.9M in Stock
United Therapeutics CEO Martine Rothblatt Sells $1.9 Million in Stock — Here’s What It Really Means for Investors ROCKVILLE, MD — Martine Rothblatt, the influential CEO of United Therapeutics (NASDAQ: UTHR) and one of the most recognizable leaders in the biotech sector, has sold 4,000 shares of company stock in a transaction worth approximately $1.92…








